Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01692561
Other study ID # WFMCMRI 001
Secondary ID JEF MRI 001
Status Completed
Phase
First received September 11, 2012
Last updated April 26, 2018
Start date August 2012
Est. completion date June 11, 2013

Study information

Verified date April 2018
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this research study is to better understand what causes dysautonomia and how this affects blood pressure and pulse. Dysautonomia is a condition of the autonomic nervous system. It is associated with fluctuations in blood pressure and pulse and may cause symptoms of nausea and belly pain, fatigue, excessive thirst, lightheadedness, dizziness, feelings of anxiety or panic, and fainting. A common example of dysautonomia is postural orthostatic tachycardia syndrome or POTS. Sometimes symptoms worsen when people move from lying down to standing, called orthostatic intolerance. We would like to learn more about the link between orthostatic intolerance and nausea. While medications currently used to treat orthostatic intolerance and nausea have proven to be effective in some patients, this may not be the best treatment for everyone as long term use could pose certain risks including high blood pressure. In order to provide a more focused and safer treatment for patients suffering from nausea and orthostatic intolerance, we have looked at how the blood pressure, pulse, and certain blood tests change during a tilt table test. This test helps to create the same circumstances that patients with orthostatic intolerance experience when they stand. To better understand if some of these problems are associated with the brain, we will study MRI in patients with dysautonomia compared to children without dysautonomia. This information may allow us to use alternative and safer treatments in the future.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date June 11, 2013
Est. primary completion date June 11, 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 9 Years to 18 Years
Eligibility Inclusion Criteria:

- subjects who have completed tilt autonomic testing

- subjects from 9 - 18 years of age

Exclusion Criteria:

- subjects who have a metabolic, mechanical, or mucosal inflammatory cause which has been defined to explain their gastrointestinal symptoms

- Patients with cardiac or cardiovascular disease, malignancy, psychiatric illness, neurodevelopmental delay, or other co-morbid conditions

- Patients with with pacemakers, implanted devices, or any other MRI contraindications will be excluded from this study.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Wake Forest University Baptist Medical Center Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of the implication of dysautonomia on the brain and better evaluate its potential mechanistic process. The first objective of the proposed project is to study central transmitter/metabolite profiles using in vivo 1H Magnetic Resonance Spectroscopy (MRS) in children with dysautonomia diagnosed by tilt table testing compared to healthy children without symptoms of dysautonomia. The second objective will be to determine whether dysautonomia associated with nausea and cardiovascular instability shares common alterations in brain networks. We will be using cognitive and sensory processing tasks based on our prior experience with both traditional fMRI and network analyses. Assessments will occur in a one and a half hour visit.
See also
  Status Clinical Trial Phase
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Completed NCT00565526 - Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
Recruiting NCT05741112 - The Long COVID-19 Wearable Device Study N/A
Active, not recruiting NCT05630040 - VNS for Long-COVID-19 N/A
Completed NCT03185247 - Implementation of Transdx Group for POTS N/A
Completed NCT01367977 - Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
Terminated NCT00221689 - Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients Phase 2
Recruiting NCT05041387 - Data Collection of Standard Care of Patients in the EMG Section
Recruiting NCT05681455 - Physiotherapy for Persistent Function by Superficial Neuromodulation N/A
Withdrawn NCT01343329 - Controlling Hyperadrenergic Activity in Neurologic Injury Phase 1/Phase 2
Active, not recruiting NCT05638620 - Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID Phase 1
Not yet recruiting NCT06073886 - Personalized Brain Stimulation to Treat Chronic Concussive Symptoms Phase 2
Completed NCT03674541 - The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Phase 2
Completed NCT05566379 - Mindfulness in Post Acute Sequelae of SARS-CoV-2 Infection (PASC) Dysautonomia N/A
Recruiting NCT05855356 - Post Covid-19 Dysautonomia Rehabilitation Randomized Controlled Trial N/A
Completed NCT04121338 - Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility Phase 1
Recruiting NCT05400174 - Blood Pressure Effects on Cognition and Brain Blood Flow in PD N/A
Recruiting NCT02931773 - Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients (ACNDM2) N/A
Not yet recruiting NCT04502199 - Dysautonomic Phenotype in Male Patients With MECP2 Mutation
Active, not recruiting NCT05515640 - Dysautonomia and Systemic Interactions in Traumatic Brain Injury